1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with prazosin in 7 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (prazosin) | Trials (prazosin) | Recent Studies (post-2010) (prazosin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 7,914 | 713 | 682 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | prazosin (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 5.87 | |
| Interstitial collagenase | Homo sapiens (human) | 4.036 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.638 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 6.963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.0078 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.29 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.647 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0007 | |
| Bromodomain-containing protein 2 | Homo sapiens (human) | 0.0009 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0006 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0006 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 4.118 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 9.9 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.5849 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Kimura, H; Miyamoto, A; Ohshika, H | 1 |
| Braillon, A; Fisher, RA; Hines, KL | 1 |
| Hsueh, W; Zhang, C | 1 |
| Baldenkov, GN; Grigorian, GIu; Mazaev, AV; Negresku, EV; Tkachuk, VA | 1 |
| Calixto, JB; Trebien, HA | 1 |
| Gerkens, JF | 1 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and prazosin
| Article | Year |
|---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Interaction between PAF and drugs that stimulate formation of inositol phosphates.
Topics: Animals; Calcium; Carbachol; In Vitro Techniques; Inositol; Inositol Phosphates; Male; Norepinephrine; Parotid Gland; Phospholipid Ethers; Platelet Activating Factor; Potassium; Prazosin; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Muscarinic | 1991 |
PAF increases hepatic vascular resistance and glycogenolysis in vivo.
Topics: Animals; Blood Pressure; Cyclic AMP; Heart Rate; Kinetics; Liver; Liver Circulation; Liver Glycogen; Male; Phenylephrine; Phosphorylase a; Platelet Activating Factor; Prazosin; Propranolol; Pulse; Rats; Rats, Inbred Strains; Vascular Resistance | 1991 |
PAF-induced bowel necrosis. Effects of vasodilators.
Topics: Alprostadil; Animals; Hydralazine; Hypotension; Indazoles; Intestinal Diseases; Leukopenia; Male; Mesenteric Arteries; Necrosis; Nitroglycerin; Phenoxybenzamine; Platelet Activating Factor; Prazosin; Rats; Rats, Inbred Strains; SRS-A; Vasodilator Agents | 1991 |
[Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+].
Topics: Blood Platelets; Calcium; Cyclic AMP; Depression, Chemical; Epinephrine; Humans; Norepinephrine; Phentolamine; Platelet Activating Factor; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Serotonin; Stimulation, Chemical; Vasopressins; Yohimbine | 1989 |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom.
Topics: Animals; Captopril; Crotalid Venoms; Dexamethasone; Edema; Hot Temperature; Indomethacin; Male; Masoprocol; Platelet Activating Factor; Prazosin; Quinacrine; Rats; Rats, Inbred Strains; Reference Values; Yohimbine | 1989 |
Inhibition of vasoconstriction by platelet activating factor in the in situ blood perfused rat mesentery.
Topics: Angiotensin II; Animals; Blood Pressure; Electric Stimulation; Male; Norepinephrine; Platelet Activating Factor; Prazosin; Quinolinium Compounds; Rats; Rats, Inbred Strains; Serotonin; Splanchnic Circulation; Vasoconstriction | 1989 |